Cell Culture-based Viral Vaccines Course, 7th Edition

Oct 2-6, 2022

Coordinators: Amine Kamen (McGill University), Yvonne Genzel (Max Planck Institute for Dynamics of Complex Technical Systems) and Francesc Gòdia (Universitat Autònoma de Barcelona)

ESACT offers an introductory intensive course in cell culture produced viral vaccines to meet the needs of the rapidly expanding research and development in academia and industry in the field. This course introduces the basic principles of vaccination and manufacturing of viral vaccines. Also, the course will provide an overview of the advanced strategies to respond to the challenges of new and established viral infection diseases.

The course has been designed to benefit those starting their research activity in this field, both from Academia, Industry or Public Health Agencies. It is also of interest for those wishing to up-date their knowledge and know-how in cell production of viral vaccines.

A limited number of grants, covering the course fee, are provided by ESACT. Applicants to the grants should indicate it in the course application, together with a motivation statement. Priority will be given to young PhD students from Academia.

The course will cover the following topics:

  • Principles of Immunology and virology
  • Cell lines for vaccine production
  • Vaccine markets and immunization policies
  • Upstream Process development and Intensification
  • Analytical and potency assays, potency assays
  • Downstream Processing of Viral Vaccines
  • Vaccine Formulation and delivery systems
  • Equipment, QbD and PAT
  • Regulatory Issues
  • Vaccine development and supply solutions

Case studies for special vaccines:

  • Recombinant vaccines: Virus like particles (VLP’s) and vectored vaccines
  • Case study: Polio vaccines: overview on history, upstream processing and regulation
  • Case study: Dengue vaccine development Vaccine approaches, clinical studies
  • Case study: Influenza vaccines: pandemic, seasonal vaccine, recombinant to egg-based vaccine

Insights from WHO and Bill and Melinda Gates Foundation

Confirmed lecturers: Amine Kamen (McGill, Canada), Leo van der Pol (IntraVac, The Netherlands), Yvonne Genzel (MPI, Germany), Francesc Gòdia (UAB, Spain), Cristina Peixoto (iBET, Portugal), Jorge Flores (PATH, USA), Emma Petiot (CPE-Lyon Engineer School, France), Isabelle Knott (GSK, Belgium), Erin Sparrow (WHO, Switzerland) and Ray Prasad (Bill and Melinda Gates Foundation, USA).

Organizing Committee

Amine Kamen
Department of Bioengineering
McGill University. 817 Sherbrooke St. W.
Macdonald Engineering Building, Room 387
Montreal, Canada
Tel.: +1(514)398 5775
Email: amine.kamen@mcgill.ca

Yvonne Genzel
Bioprocess Engineering Group, Team Upstream Processing
Max Planck Institute for Dynamics of Complex Technical Systems
Sandtorstr. 1, 39106 Magdeburg, Germany
Tel +49 391 6110 257
Email: genzel@mpi-magdeburg.mpg.de

Francesc Gòdia
Departament d’Enginyeria Quimica, Biològica i Ambiental
Escola d‘Enginyeria, Edifici Q, Universitat Autònoma de Barcelona,
Bellaterra, Barcelona 08193, Spain
Tel.: +34 93 581 4790
Email: francesc.godia@uab.cat

Contact for registration

Birgit Marckhgott
Email: office@esact.org

Application for ESACT Cell Culture-based Viral Vaccines Course, 7th Edition

Application is already open now! – By filling out and submitting the contact form below, you are applying to join the course. The Selection of participants will be based solely on the strength of your motivation letter and your CV (in case of
applying for a grant). It does not depend on the date of receipt of the application.